Basit öğe kaydını göster

dc.contributor.authorHarmanci, Ozgur
dc.contributor.authorBayraktar, Yusuf
dc.date.accessioned2019-12-10T11:13:31Z
dc.date.available2019-12-10T11:13:31Z
dc.date.issued2008
dc.identifier.issn1007-9327
dc.identifier.urihttps://doi.org/10.3748/wjg.14.3968
dc.identifier.urihttp://hdl.handle.net/11655/15081
dc.description.abstractGaucher disease (GD) is an autosomal recessive disease which if undiagnosed or diagnosed late results in devastating complications. Because of the heterozygous nature of GD, there is a wide spectrum of clinical presentation. Clinicians should be aware of this rare but potentially treatable disease in patients who present with unexplained organomegaly, anemia, massive splenomegaly, ascites and even cirrhosis of unknown origin. The treatment options for adult type GD include enzyme replacement treatment (ERT) and substrate reduction treatment (SRT) depending on the status of the patient. Future treatment options are gene therapy and "smart molecules" which provide specific cure and additional treatment options. In this review, we present the key issues about GD and new developments that gastroenterologists should be aware Of. (C) 2008 The WJG Press. All rights reserved.
dc.language.isoen
dc.publisherW J G Press
dc.relation.isversionof10.3748/wjg.14.3968
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGastroenterology & Hepatology
dc.titleGaucher Disease: New Developments In Treatment And Etiology
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalWorld Journal Of Gastroenterology
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume14
dc.identifier.issue25
dc.identifier.startpage3968
dc.identifier.endpage3973
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster